Nutrient Synergy
Alumis lupus drug advances after trial setback
By Samoyed · 226
Somatic Drills
ESC 2026 AstraZeneca oral relaxin passes Phase II
By Samoyed · 192
Endocrine Balance
Novartis Announces Positive Phase III Results for Remibrutinib
By Samoyed · 174
Recovery Modalities
HiRO and Differentia Biotech collaborate on trial simulation
By emily johnson · 352 Views · August 31, 2026
Microbiome Diversity 
Microbiome Diversity 
Recovery Modalities
Daiichi Sankyo Begins Phase I DS1025 Trial
First patient dosing has begun in the Phase I DS1025 study , a trial that will assess an...
August 29, 2026
Editor's picks
Why Is Medicaid Member Engagement Essential for Health
Medicaid is a cornerstone of healthcare access for millions of Americans, including low-income families, seniors, and individuals with disabilities. While...
August 27, 2026
ESC 2026 AstraZeneca oral relaxin passes Phase II
AstraZeneca's AZD5462 shows promise in Phase II trial for chronic heart failure, improving cardiac function via relaxin pathway.
September 2, 2026
ESC 2026 AstraZeneca oral relaxin passes Phase II
By Samoyed · Sep 2, 2026
Why Is Medicaid Member Engagement Essential for Health
By Samoyed · Aug 27, 2026
All Post
Nutrient Synergy
Alumis lupus drug advances after trial setback
Alumis advances its lupus drug to Phase III trials despite mixed Phase IIb results, targeting a specific patient subgroup for better outcomes.
Samoyed 171 Views September 3, 2026
Somatic Drills
ESC 2026 AstraZeneca oral relaxin passes Phase II
AstraZeneca's AZD5462 shows promise in Phase II trial for chronic heart failure, improving cardiac function via relaxin pathway.
Samoyed 277 Views September 2, 2026
Endocrine Balance
Novartis Announces Positive Phase III Results for Remibrutinib
Novartis announces positive Phase III results for Remibrutinib, a new oral treatment for relapsing multiple sclerosis showing significant efficacy over teriflun
Samoyed 179 Views September 1, 2026
Recovery Modalities
HiRO and Differentia Biotech collaborate on trial simulation
HiRO and Differentia Biotech collaborate on advanced clinical trial simulation models. Learn how this AI-driven partnership aims to support biopharmaceutical sp
emily johnson 97 Views August 31, 2026
Microbiome Diversity
HaemaLogiX doses KMCAR T‑cell in KOALA trial
Discover the KMCAR T-cell dose in the KOALA Phase I trial, a promising CAR‑T option for relapsed or refractory kappa‑restricted multiple myeloma patients.
Samoyed 265 Views August 30, 2026
Endocrine Balance
Amgen Drug Shows Promise in Inflammatory Diseases
Amgen's new drug shows promise in treating inflammatory diseases, potentially securing a new label addition for severe conditions like asthma and eosinophilic o
Samoyed 181 Views August 29, 2026
Recovery Modalities
Daiichi Sankyo Begins Phase I DS1025 Trial
First patient dosing has begun in the Phase I DS1025 study , a trial that will assess an investigational antibody‑drug conjugate in adults with advanced.
Samoyed 273 Views August 29, 2026
Microbiome Diversity
Lab Grown Diamond Rings Are Aot Just For Engagements.
When it comes to purchasing diamond rings, many people think of engagements as the only occasion to do so. However, lab grown diamond rings can be a perfect fit for other significant events in your...
Samoyed 168 Views August 28, 2026
Endocrine Balance
Manchester’s Sustainable Spark: Exploring Lab-Grown Diamond Engagement Rings
In the heart of the vibrant city of Manchester, a new trend is emerging that combines luxury with sustainability: lab grown diamond engagement rings. As more people become conscious of their environmental impact, the demand...
Samoyed 276 Views August 28, 2026
Somatic Drills
Why Is Medicaid Member Engagement Essential for Health
Medicaid is a cornerstone of healthcare access for millions of Americans, including low-income families, seniors, and individuals with disabilities. While enrollment provides access to healthcare services, coverage alone is not enough. True health improvement depends...
Samoyed 240 Views August 27, 2026